Pharmacological Inhibition of Hsp90 as a Novel Antitumor Strategy to Target Cytoarchitecture Through Extracellular Matrix Signaling

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|7|5|454-465

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.7, Iss.5, 2011-09, pp. : 454-465

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hsp90: A Novel Target for the Disruption of Multiple Signaling Cascades

By  

Current Cancer Drug Targets, Vol. 7, Iss. 4, 2007-06 ,pp. : 369-388

Bentham Science Publishers

Access to resources Recommend Favorite

Hsp90: A Novel Target for Cancer Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-06 ,pp. : 1205-1214

Bentham Science Publishers

Access to resources Recommend Favorite

The Adiponectin Signaling Pathway as a Novel Pharmacological Target

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 12, 2006-12 ,pp. : 1331-1340

Bentham Science Publishers

Access to resources Recommend Favorite

HSP90 Inhibitors: Multi-Targeted Antitumor Effects and Novel Combinatorial Therapeutic Approaches in Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 16, Iss. 24, 2009-08 ,pp. : 3081-3092

Bentham Science Publishers

Access to resources Recommend Favorite

Multiclass Comparative Virtual Screening to Identify Novel Hsp90 Inhibitors: A Therapeutic Breast Cancer Drug Target

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 1, 2015-01 ,pp. : 57-64

Bentham Science Publishers

Access to resources Recommend Favorite